Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy
Crossref DOI link: https://doi.org/10.1007/s11255-017-1639-2
Published Online: 2017-06-27
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Jing
Ai, Xiaobo
Li, Li
Gao, Yanyan
Sun, Nina
Li, Changgui
Sun, Weihong
Funding for this research was provided by:
the key project of Qingdao Health Bureau grant (10-4-2-5-jch)
License valid from 2017-06-27